- Home
- RMCF vs BGLC Comparison
RMCF vs BGLC Comparison
Compare RMCF & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMCF
- BGLC
- Stock Information
- Founded
- RMCF 1981
- BGLC 2017
- Country
- RMCF United States
- BGLC Malaysia
- Employees
- RMCF N/A
- BGLC N/A
- Industry
- RMCF Specialty Foods
- BGLC Medical Specialities
- Sector
- RMCF Consumer Staples
- BGLC Health Care
- Exchange
- RMCF Nasdaq
- BGLC Nasdaq
- Market Cap
- RMCF 11.6M
- BGLC 10.7M
- IPO Year
- RMCF N/A
- BGLC N/A
- Fundamental
- Price
- RMCF $1.48
- BGLC $5.63
- Analyst Decision
- RMCF
- BGLC
- Analyst Count
- RMCF 0
- BGLC 0
- Target Price
- RMCF N/A
- BGLC N/A
- AVG Volume (30 Days)
- RMCF 22.7K
- BGLC 3.1M
- Earning Date
- RMCF 10-14-2025
- BGLC 08-18-2025
- Dividend Yield
- RMCF N/A
- BGLC N/A
- EPS Growth
- RMCF N/A
- BGLC N/A
- EPS
- RMCF N/A
- BGLC N/A
- Revenue
- RMCF $29,545,000.00
- BGLC $9,551,559.00
- Revenue This Year
- RMCF N/A
- BGLC N/A
- Revenue Next Year
- RMCF N/A
- BGLC N/A
- P/E Ratio
- RMCF N/A
- BGLC N/A
- Revenue Growth
- RMCF 5.81
- BGLC 4.01
- 52 Week Low
- RMCF $1.12
- BGLC $2.01
- 52 Week High
- RMCF $3.49
- BGLC $15.60
- Technical
- Relative Strength Index (RSI)
- RMCF 42.85
- BGLC 52.39
- Support Level
- RMCF $1.39
- BGLC $5.21
- Resistance Level
- RMCF $1.53
- BGLC $5.72
- Average True Range (ATR)
- RMCF 0.10
- BGLC 0.35
- MACD
- RMCF -0.01
- BGLC -0.06
- Stochastic Oscillator
- RMCF 33.48
- BGLC 33.11
About RMCF Rocky Mountain Chocolate Factory Inc.
Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, U-Swirl Operations, and Other t. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.